Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Update

Scienture Holdings, Inc. (NASDAQ:SCNX) saw a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 2,600,386 shares, an increase of 177.8% from the June 30th total of 935,988 shares. Based on an average daily trading volume, of 7,329,646 shares, the days-to-cover ratio is currently 0.4 days. Currently, 8.1% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a research report on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Scienture currently has a consensus rating of “Hold” and an average target price of $1.50.

Scienture Stock Down 2.0%

Shares of NASDAQ:SCNX traded down $0.01 during midday trading on Monday, reaching $0.36. The company’s stock had a trading volume of 407,668 shares, compared to its average volume of 2,208,575. The firm has a 50 day moving average of $0.38 and a 200-day moving average of $0.41. The firm has a market capitalization of $14.71 million, a P/E ratio of -0.14 and a beta of 3.28. Scienture has a 12-month low of $0.24 and a 12-month high of $2.60.

Scienture (NASDAQ:SCNX) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.15. The business had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.40 million.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Scienture stock. Virtu Financial LLC purchased a new stake in shares of Scienture Holdings, Inc. (NASDAQ:SCNX) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned approximately 0.22% of Scienture at the end of the most recent reporting period. 5.68% of the stock is owned by hedge funds and other institutional investors.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.